Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 3268-3272

  Bollen, Wendy S ^a,d   Gunn, Bronwyn M ^a,b,e   Mo, Hua ^b   Lay, Margarita K ^a,f   Curtiss III, Roy ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d Agnesian Healthcare   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALMONELLOSIS VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BLOOD SAMPLING; BRAIN INFECTION; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE MUTATION; IMMUNIZATION; INOCULATION; INVA GENE; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BRAIN; DRUG ADMINISTRATION ROUTE; GENETICS; HUMAN; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; OLFACTORY BULB; ORAL DRUG ADMINISTRATION; PATHOGENICITY; SALMONELLA TYPHI;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; BLOOD; BRAIN; DRUG ADMINISTRATION ROUTES; HUMANS; MICE; MICE, INBRED BALB C; OLFACTORY BULB; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; VACCINES, ATTENUATED;

EID: 46449135736     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00244-08     Document Type: Article

References (30)

1. Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
2. Bollen, W. S., B. Gunn, M. Lay, and R. Curtiss III. 2003. Colonization of the brain following intranasal inoculation with Salmonella, abstr. E-088, p. 265-266. Abstr. 103rd Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
3. Curtiss, R., III. 1965. Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J. Bacteriol. 89:28-40.
4. Curtiss, R., III. 1990. Attenuated Salmonella strains as live vectors for the expression of foreign antigens, p. 715-740. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, New York, NY.
5. Curtiss, R., III, T. Doggett, A. Nayak, and J. Srinivasan. 1996. Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization, p. 499-511. In H. Kiyono and M. F. Kagnoff (ed.), Essentials of mucosal immunology. Academic Press, San Diego, CA.
6. Curtiss, R., III., S. B. Porter, M. Munson, S. A. Tinge, J. O. Hassan, C. Gentry-Weeks, and S. M. Kelly. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p. 169-198. In L. C. Blankenship, J. S. Bailey, N. A. Cox, S. E. Craven, R. J. Meinersmann, and N. J. Stern (ed.), Colonization control of human bacterial enteropathogens in poultry. Academic Press, Inc., New York, NY.
7. Denis, F., S. Badiane, J. P. Chiron, A. Sow, and I. D. Mar. 1977. Salmonella meningitis in infants. Lancet 1:910.
8. Fang, F. C., S. J. Libby, N. A. Buchmeier, P. C. Loewen, J. Switala, J. Harwood, and D. G. Guiney. 1992. The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc. Natl. Acad. Sci. USA 89:11978-11982.
9. Galán, J. E., and R. Curtiss III. 1989. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc. Natl. Acad. Sci. USA 86:6383-6387.
10. Galen, J. E., O. G. Gomez-Duarte, G. A. Losonsky, J. L. Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708.
11. Gulig, P. A., and R. Curtiss III. 1987. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 55:2891-2901.
12. Gunn, B., X. Zhang, S. Y. Wanda, and R. Curtiss III. 2007. Safety of recombinant attenuated Salmonella vaccines (RASV) in infant mice, abstr. E-063, p. 278. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
13. Henderson, L. L. 1948. Salmonella meningitis: report of three cases and review of one hundred and forty-four cases from the literature. Am. J. Dis. Child. 75:351-375.
14. Hengge-Aronis, R. 2000. A role for the sigma S subunit of RNA polymerase in the regulation of bacterial virulence. Adv. Exp. Med. Biol. 485:85-93.
15. Hopkins, S., J. P. Kraehenbuhl, F. Schödel, A. Potts, D. Peterson, P. de Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
16. Kang, H. Y., C. M. Dozois, S. A. Tinge, T. H. Lee, and R. Curtiss III. 2002. Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J. Bacteriol. 184:307-312.
17. Karim, M., and N. Islam. 2002. Salmonella meningitis: report of three cases in adults and literature review. Infection 30:104-108.
18. Kauffman, C. A., and R. J. St Hilaire. 1979. Salmonella meningitis. Occurrence in an adult. Arch. Neurol. 36:578-580.
19. Medina, E., and C. A. Guzman. 2001. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19:1573-1580.
20. Mielcarek, N., S. Alonso, and C. Locht. 2001. Nasal vaccination using live bacterial vectors. Adv. Drug Delivery Rev. 51:55-69.
21. Olsen, S. J., R. Bishop, F. W. Brenner, T. H. Roels, N. Bean, R. V. Tauxe, and L. Slutsker. 2001. The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997. J. Infect. Dis. 183:753-761.
22. Pasetti, M. F., T. E. Pickett, M. M. Levine, and M. B. Sztein. 2000. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model. Vaccine 18:3208-3213.
23. + major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect. Immun. 70:4009-4018.
24. Santander, J., S. Y. Wanda, C. A. Nickerson, and R. Curtiss III. 2007. Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect. Immun. 75:1382-1392.
25. Sebastiani, G., V. Blais, V. Sancho, S. N. Vogel, M. M. Stevenson, P. Gros, J. M. Lapointe, S. Rivest, and D. Malo. 2002. Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains. Infect. Immun. 70:1997-2009.
26. Srinivasan, J., A. Nayak, R. Curtiss III, and S. Rubino. 1995. Effect of the route of immunization using recombinant Salmonella on mucosal and humoral immune responses, p. 273-280. In R. M. Chanock, F. Brown, H. S. Ginsberg, and E. Norrby (ed.), Vaccines 95. Cold Spring Harbor Laboratory Press, Plainview, NY.
27. Tacket, C. O., D. M. Hone, R. Curtiss III, S. M. Kelly, G. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992. Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect. Immun. 60:536-541.
28. Uysal, H., A. Karademir, M. Kilinc, and O. Erturk. 2001. Salmonella encephalopathy with seizure and frontal intermittent rhythmic delta activity. Infection 29:103-106.
29. Vazquez-Torres, A., J. Jones-Carson, A. J. Bäumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808.
30. Wickham, M. E., N. F. Brown, J. Provias, B. B. Finlay, and B. K. Coombes. 2007. Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain. BMC Infect. Dis. 7:65.